Claim Missing Document
Check
Articles

Found 2 Documents
Search

Seroma as a Biological Tissue Expander on Post-Mastectomy Reconstruction: A Case Report Kurnia, Ahmad; Muazdhani, Fatahillah
The New Ropanasuri Journal of Surgery Vol. 8, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction. Previous studies have reported that patient satisfaction with breast cancer management is related to the success of breast reconstruction. The tissue expander used in breast reconstruction today has several disadvantages: the high cost, the nature of the foreign body, and the risk of failure. Seroma has the potential as a natural tissue developer in post-mastectomy reconstruction. This case report aims to describe the technique, results, advantages, and limitations of post-mastectomy breast reconstruction using a seroma as a natural tissue expander that has never been done before. Case Presentation. A 37-year-old woman was diagnosed with stage IIIA non-special type (NST) invasive breast carcinoma stage III without lymphovascular invasion. The patient underwent a modified radical mastectomy (MRM) on the right side breast. Postoperatively, a drain was placed for observation. If no maceration of the skin was found, the drain was removed within the first 24 hours postoperatively to accumulate seroma in the dead space formed in the breast flap. Next, seroma molding is done with a special bra that fits the shape of the bust. Observations were made during the treatment, and the seroma molding process occurred. During the follow-up period, the patient complained of mild pain and did not experience tumor recurrence. Conclusion. This case report shows seroma as a biological tissue expander that can potentially be used as an alternative breast reconstruction method with body fluid accumulation.
Correlation of Thyroid Stimulating Hormone (TSH), T3, and T4 Hormones with Histopathological Characteristics of Thyroid Cancer at Cipto Mangunkusumo General Hospital Kurnia, Ahmad; Bangun, Kristaninta; Muazdhani, Fatahillah
The New Ropanasuri Journal of Surgery Vol. 8, No. 3
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction. In a study spanning 2008 to 2012 at Cipto Mangunkusumo General Hospital (CMGH) Jakarta, 668 cases of thyroid cancer were identified among 18,216 cancer cases. Globally, the papillary subtype is prevalent, and prior research indicates a link between thyroid hormone changes and thyroid carcinoma risk. To improve surgical care, this study aims to find the association between thyroid hormone levels and histological subtypes in thyroid carcinoma patients. Method. This cross-sectional study focused on thyroid cancer patients managed from 2013 to 2017. Despite subjects' characteristics, thyroid hormone levels and histopathological findings were the variables of interest. The findings were analyzed using ANOVA, Kruskal-Wallis, unpaired T-tests, Mann-Whitney tests, and Pearson or Spearman tests to find correlations with age, gender, clinical presentation, and body mass index. Results. The mean age was 48.7 years, with subjects having an average body weight of 64.5 kg, height of 154.4 cm, and BMI of 24.8 kg/m2. Hormonal analysis revealed mean T3 levels at 2.02 ng/mL, T4 levels were slightly lower at 1.92 ng/mL, and TSH levels were the lowest at 1.22 ng/mL. A very weak correlation existed between the T3 hormone and age (r = 0.05, p = 0.77). In the correlation between T4 thyroid hormone levels and age, a weak correlation was found between T4 thyroid hormone levels and age (r = 0.31, p = 0.08). In the correlation between thyroid cancer histopathology and gender, clinical presentation, and BMI, there was no significant association with gender, ?s = 0,01; 95% ??? [-3,37; 3.34]; p=0,94 Conclusion. This study indicates that the TSH, T3, and T4 hormone levels were not associated with the histopathological characteristics of thyroid cancer at CMGH. The T3, T4, and TSH hormone levels were unaffected by gender, nodule involvement, and age